Epstein Secrets

5.552.0 2.937.9 315x: Marta90 /54% 10.06 IPA% 9,014 52% LB1T 8.1021 3309.1 3.103 ANTS 5714 LIM a 4104.6"/ 124% 40% 54% Al% 14% Methodist 53724 1277.0 2.4203 16165 µA NS mans., 4%. 7.4% 2..”4 4.1% 4.3% 5:4 3 ) 01109 1PS 1.47 034 067 0.71 025 5'nh lba SuMwinl 7,4, Mt

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

5.552.0 2.937.9 315x: Marta90 /54% 10.06 IPA% 9,014 52% LB1T 8.1021 3309.1 3.103 ANTS 5714 LIM a 4104.6"/ 124% 40% 54% Al% 14% Methodist 53724 1277.0 2.4203 16165 µA NS mans., 4%. 7.4% 2..”4 4.1% 4.3% 5:4 3 ) 01109 1PS 1.47 034 067 0.71 025 5'nh lba SuMwinl 7,4, Mt

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

5.552.0 2.937.9 315x: Marta90 /54% 10.06 IPA% 9,014 52% LB1T 8.1021 3309.1 3.103 ANTS 5714 LIM a 4104.6"/ 124% 40% 54% Al% 14% Methodist 53724 1277.0 2.4203 16165 µA NS mans., 4%. 7.4% 2..”4 4.1% 4.3% 5:4 3 ) 01109 1PS 1.47 034 067 0.71 025 5'nh lba SuMwinl 7,4, Mt

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha